Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,165,108
  • Shares Outstanding, K 71,338
  • Annual Sales, $ 538,590 K
  • Annual Income, $ -523,900 K
  • 60-Month Beta 0.89
  • Price/Sales 4.06
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PTCT with:

Options Overview Details

View History
  • Implied Volatility 75.10% ( -3.94%)
  • Historical Volatility 53.12%
  • IV Percentile 96%
  • IV Rank 85.49%
  • IV High 81.54% on 12/03/21
  • IV Low 37.21% on 11/04/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 40
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 2,216
  • Open Int (30-Day) 1,262

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -1.67
  • Number of Estimates 6
  • High Estimate -1.45
  • Low Estimate -1.90
  • Prior Year -1.68
  • Growth Rate Est. (year over year) +0.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.94 +1.37%
on 05/25/22
37.45 -18.96%
on 04/28/22
-6.80 (-18.30%)
since 04/27/22
3-Month
29.94 +1.37%
on 05/25/22
45.80 -33.73%
on 04/14/22
-5.32 (-14.91%)
since 02/25/22
52-Week
29.94 +1.37%
on 05/25/22
45.80 -33.73%
on 04/14/22
-8.81 (-22.50%)
since 05/27/21

Most Recent Stories

More News
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -14.84% and 2.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PTCT : 30.35 (-0.88%)
AZYO : 6.29 (+6.97%)
PTC Therapeutics (PTCT) Soars 11.1%: Is Further Upside Left in the Stock?

PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

PTCT : 30.35 (-0.88%)
ASRT : 3.11 (+0.65%)
United Therapeutics (UTHR) Moves 3.1% Higher: Will This Strength Last?

United Therapeutics (UTHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term....

UTHR : 235.83 (+4.92%)
PTCT : 30.35 (-0.88%)
PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -13.41% and 1.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

PTCT : 30.35 (-0.88%)
XERS : 2.26 (+13.00%)
Is a Surprise Coming for PTC Therapeutics (PTCT) This Earnings Season?

PTC Therapeutics (PTCT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

PTCT : 30.35 (-0.88%)
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Should You Buy?

PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PTCT : 30.35 (-0.88%)
Strength Seen in PTC Therapeutics (PTCT): Can Its 5.1% Jump Turn into More Strength?

PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

PTCT : 30.35 (-0.88%)
PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -6.18% and 16.25%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

PTCT : 30.35 (-0.88%)
PTC Therapeutics: Q3 Earnings Snapshot

SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $133.6 million in its third quarter.

PTCT : 30.35 (-0.88%)
PTC Therapeutics Provides a Corporate Update and Reports Third Quarter 2021 Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the third quarter ending September 30, 2021....

PTCT : 30.35 (-0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 32.54
2nd Resistance Point 31.97
1st Resistance Point 31.16
Last Price 30.35
1st Support Level 29.78
2nd Support Level 29.21
3rd Support Level 28.40

See More

52-Week High 45.80
Fibonacci 61.8% 39.74
Fibonacci 50% 37.87
Fibonacci 38.2% 36.00
Last Price 30.35
52-Week Low 29.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar